Related Experiment Videos
In vivo/in vitro labeling of red blood cells with 99mTc
Insights
This study presents a rapid in vivo/in vitro red blood cell (RBC) labeling technique using 99mTc, achieving high labeling yields with both Sn-DTPA and Sn-PYP pretinning methods. The efficient and safe procedure is suitable for various nuclear medicine applications.
Area of Science:
- Nuclear Medicine
- Radiopharmacy
- Biomedical Imaging
Background:
- Red blood cell (RBC) labeling is crucial for various diagnostic imaging procedures.
- Optimizing labeling efficiency and reducing procedure time are key goals in nuclear medicine.
- In vivo/in vitro labeling methods offer advantages in certain clinical scenarios.
Purpose of the Study:
- To evaluate a novel in vivo/in vitro red blood cell (RBC) labeling method using Technetium-99m (99mTc).
- To assess the efficacy and safety of two different stannous pretreatment solutions (Sn-DTPA and Sn-PYP).
- To determine the labeling yield and applicability of the method in a large patient cohort.
Main Methods:
- Red blood cells (RBCs) were labeled with 99mTc following in vivo pretreatment with either Sn-DTPA or Sn-PYP.
- The entire labeling procedure, encompassing both in vivo and in vitro steps, was completed within 30-40 minutes.
- Labeling yields were assessed in 1,356 patients.
Main Results:
- Mean labeling yields were high: 89.7% with Sn-DTPA and 88.2% with Sn-PYP.
- Median labeling yields were also favorable: 94% for Sn-DTPA and 92% for Sn-PYP.
- The method demonstrated successful application in over 2,000 radionuclide-ventriculography studies and 38 gastrointestinal bleeding investigations, with no observed adverse effects.
Conclusions:
- The described in vivo/in vitro RBC labeling technique with 99mTc is efficient and reliable.
- Both Sn-DTPA and Sn-PYP pretinning methods provide excellent labeling yields.
- This rapid and safe labeling procedure is well-suited for clinical nuclear medicine imaging, including ventriculography and bleeding localization.
Abstract:
Red blood cells (RBC) were labeled with 99mTc in vitro after in vivo pretreatment with a stannous solution. The whole in vivo/in vitro procedure took 30-40 min. Pretinning was carried out by injection of either 6 mg DTPA and 0.6 mg Sn++ (Sn-DTPA) or 5 mg pyrophosphate and 0.7 mg Sn++ (Sn-PYP). The results of 1,356 patients were evaluated. The labeling yield was 89.7% (mean) after pretinning with Sn-DTPA and 88.2% following Sn-PYP pretreatment, the median values being 94% and 92%, respectively. The new method was successfully used in over 2,000 patients who had a radionuclide-ventriculography and in 38 patients studied for localization of occult gastrointestinal bleeding. Adverse side effects have never been observed.